Symbol="ABEO"
AssetType="Common Stock"
Name="Abeona Therapeutics Inc"
Description="Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for rare, life-threatening genetic diseases. The company is headquartered in New York, New York."
CIK="318306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1330 AVENUE OF THE AMERICAS, 33RD FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="99073000"
EBITDA="-42238000"
PERatio="None"
PEGRatio="0"
BookValue="0.435"
DividendPerShare="0"
DividendYield="0"
EPS="-1.85"
RevenuePerShareTTM="0.261"
ProfitMargin="0"
OperatingMarginTTM="-12.62"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-2.672"
RevenueTTM="3568000"
GrossProfitTTM="-28001000"
DilutedEPSTTM="-1.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.5"
AnalystTargetPrice="21"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.71"
PriceToBookRatio="3.31"
EVToRevenue="9.47"
EVToEBITDA="-0.515"
Beta="1.346"
num_52WeekHigh="5.8"
num_52WeekLow="2.19"
num_50DayMovingAverage="3.869"
num_200DayMovingAverage="3.236"
SharesOutstanding="24755900"
DividendDate="None"
ExDividendDate="None"
symbol="ABEO"
open="4.16"
high="4.19"
low="3.82"
price="3.94"
volume="85852.00"
latest_trading_day="2023-08-24"
previous_close="4.13"
change="-0.19"
change_percent="-4.6005%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="13"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="87"
Volume_recent_avg="153919"
Change_recent_avg="0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="87"
Aroon_momentum_negative="13"
image_negative_thumbnail_id_1="134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_negative_thumbnail_id_2="92"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="988"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_positive_thumbnail_id_2="627"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0081.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
